OUTCOMES IN PATIENTS RESUMING INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOLLOWING TREATMENT DELAY DURING THE CORONAVIRUS-19 PANDEMIC.

Rush, Ryan B; Rush, Sloan W

Rush, Ryan B; Rush, Sloan W.

Affiliation

Rush RB; Panhandle Eye Group, Amarillo, Texas.
Rush SW; Texas Tech University Health Science Center, Amarillo, Texas; and.

Retina ; 41(12): 2456-2461, 2021 12 01.

Article in En | MEDLINE | ID: mdl-34369441

Subject(s)

Angiogenesis Inhibitors/therapeutic use; COVID-19/epidemiology; Retinal Diseases/drug therapy; SARS-CoV-2; Vascular Endothelial Growth Factor A/antagonists & inhibitors; Aged; Bevacizumab/therapeutic use; Choroidal Neovascularization/drug therapy; Choroidal Neovascularization/physiopathology; Continuity of Patient Care; Diabetic Retinopathy/drug therapy; Diabetic Retinopathy/physiopathology; Female; Humans; Intravitreal Injections; Macular Edema/drug therapy; Macular Edema/physiopathology; Male; Outcome Assessment, Health Care; Ranibizumab/therapeutic use; Retinal Diseases/physiopathology; Retinal Vein Occlusion/drug therapy; Retinal Vein Occlusion/physiopathology; Retrospective Studies; Time-to-Treatment; United States/epidemiology; Visual Acuity/physiology; Wet Macular Degeneration/drug therapy; Wet Macular Degeneration/physiopathology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinal Diseases / Angiogenesis Inhibitors / Vascular Endothelial Growth Factor A / SARS-CoV-2 / COVID-19 Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Retina Year: 2021 Type: Article

Fulltext

XML

PubMed Links

Search on Google